The role of ingredient toxicological profiles in cosmetic safety assessment

The toxicological profile sits at the core of every cosmetic product safety assessment, even though it rarely gets the same attention as ingredient lists or claims. Under Regulation (EC) No 1223/2009, no cosmetic product can be placed on the European Union (EU) market without a Cosmetic Product Safety Report (CPSR), and within that report, the toxicological profile of each substance is what ultimately determines whether a formulation can be considered safe for its intended use. 

Where it fits in the CPSR  

Annex I to the Regulation sets out the minimum content of the CPSR in two parts:

• Part A gathers the safety information itself, and the toxicological profile of the substances is listed as its own dedicated section, distinct from composition, exposure, or microbiological quality. 
• Part B then builds on that information to produce the actual safety assessment, which by law must be carried out by a suitably qualified safety assessor. In practice, the toxicological profile is the evidence base the assessor relies on to reach a conclusion, so its quality directly shapes the reliability of that conclusion. 

What the profile needs to cover 

Guidelines issued by the European Commission clarify what a toxicological profile should address for each substance: 

• • the relevant toxicological endpoints;
  • the routes of absorption that apply;
  • whether dermal, oral, or inhalation, and;
  • how systemic effects are considered when calculating the margin of safety.

This is the technical backbone that lets an assessor justify, on record, that a given concentration of a given ingredient is safe in a given product. 

Why this becomes harder at scale 

For a single product, pulling together toxicological data on each ingredient is manageable. The difficulty grows with the number of products being managed. Formulators reuse ingredients across many products, in different concentrations and combinations, and each new formulation technically calls for its toxicological data to be checked against that specific context of use.

Keeping this information organized, current, and traceable back to its original source becomes a significant undertaking once a company is managing dozens or hundreds of products, especially as new studies or regulatory opinions occasionally revise what's known about a given substance. 

How Cosmedesk supports this process 

We compile and maintain toxicological profiles for cosmetic ingredients, drawing on recognized sources and structuring the data in the format safety assessors need for the CPSR, covering toxicological endpoints, absorption routes, and the supporting references behind each conclusion. It doesn't replace the assessor's own judgment or the assessment itself, but it removes a substantial amount of the groundwork that judgment depends on. 

A robust toxicological profile is what turns a safety assessment from an assumption into a documented conclusion. As cosmetic formulations and ingredient database keep growing, having that groundwork reliably in place is less a convenience and more a basic condition for compliance. 

Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products Commission Implementing Decision of 25 November 2013 on Guidelines on Annex I to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (2013/674/EU)